These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3534307)

  • 21. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
    Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
    J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Defense mechanisms of the macro-organism in bacteriuria in chronic pyelonephritis].
    Falkenhagen U; Wendt M; Hilbert R; Zingler G
    Z Urol Nephrol; 1986 Nov; 79(11):619-27. PubMed ID: 3551386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of complement in chemotaxis: study of a localized infection.
    Wilson DM; Ormrod DJ; Miller TE
    Infect Immun; 1980 Jul; 29(1):8-12. PubMed ID: 6995344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology of pyelonephritis. III. Effect of colloidal carbon.
    Angel JA; Roberts JA; Smith TW; Di Luzio NR
    J Urol; 1982 Sep; 128(3):624-8. PubMed ID: 6750151
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
    Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of certain immunological mechanism in experimental pyelonephritis in rabbits. II. Bacterio-immunological studies].
    Gelber J; Sliwińska H; Rydzewska E; Pozorska D
    Pediatr Pol; 1970 Jan; 45(1):21-31. PubMed ID: 4905194
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular basis of host defence in pyelonephritis. I. Chronic infection.
    Miller TE; Findon G; Cawley S
    Br J Exp Pathol; 1986 Feb; 67(1):13-23. PubMed ID: 3511938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-fimbriae receptors in patients with chronic pyelonephritis.
    Jacobson SH; Källenius G; Lins LE; Svenson SB
    J Urol; 1988 May; 139(5):900-3. PubMed ID: 2896254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice.
    Khalil A; Tullus K; Bartfai T; Bakhiet M; Jaremko G; Brauner A
    Clin Exp Immunol; 2000 Nov; 122(2):200-6. PubMed ID: 11091275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of complement-derived and bacterial formylpeptide chemotactic factors in the in vivo migration of neutrophils in experimental Escherichia coli pyelonephritis in rats.
    Meylan PR; Glauser MP
    J Infect Dis; 1989 May; 159(5):959-65. PubMed ID: 2540249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoglobulins in the serum of chronic pyelonephritis patients].
    Gruev I; Kiperova B; Mavromatis T; Altŭnkova I; Bocheva S
    Vutr Boles; 1986; 25(1):21-8. PubMed ID: 3087065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamics of immunological changes in rabbits with experimental pyelonephritis].
    Shvedov LM; Skosogorenko MG; Ukhal' MI
    Urol Nefrol (Mosk); 1974; 0(5):10-3. PubMed ID: 4607553
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of interferon on the course of experimental E coli-induced pyelonephritis].
    Rudenko AV; Maĭdannik VG; Pavlenko VA; Spivak NIa; Romanenko AM; Ishchenko EM; Glebova LP; Bavina EN
    Antibiot Khimioter; 1990 Jan; 35(1):32-5. PubMed ID: 2185709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norwich-Eaton lectureship. Pathogenesis of nonobstructive urinary tract infections in children.
    Roberts JA
    J Urol; 1990 Aug; 144(2 Pt 2):475-9; discussion 480. PubMed ID: 2374223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.
    Hertting O; Khalil A; Jaremko G; Chromek M; Li YH; Bakhiet M; Bartfai T; Tullus K; Brauner A
    Clin Exp Immunol; 2003 Feb; 131(2):225-33. PubMed ID: 12562381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal collecting duct cells act as modulators of the innate immune response during ascending pyelonephritis].
    Vandewalle A; Chassin C
    Med Sci (Paris); 2009 Mar; 25(3):224-6. PubMed ID: 19361380
    [No Abstract]   [Full Text] [Related]  

  • 40. [Humoral and cellular factors of immunological defense against infection exemplified by estrogen-facilitated pyelonephritis in rats].
    Freiesleben H; Sack K; Woermann K; Henkel W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):314-20. PubMed ID: 4154603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.